Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Injection Location in Interstitial Cystitis
NCT02297100Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2014
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in interstitial cystitis (IC), sponsored by Wake Forest University Health Sciences. Started Dec 2014; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT02297100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297100.